SUMMARY Leukocyte glutamate dehydrogenase (GDH) activity was measured in 39 normal subjects, 32 neurological controls, 66 patients with progressive ataxic disorders, 32 with multiple system atrophy, 40 with Parkinson's disease, eight with Steele-Richardson-Olszewski syndrome, eight with juvenile Parkinsonism and four with the dystonia-Parkinsonism syndrome. GDH activity was reproducible to within 10% in leukocyte pellets stored at -70°C for up to 9 months, and did not vary with sex or age in control subjects. There was marked variation in the relative proportions of heat stable and heat labile forms of GDH between control subjects and on repeated assay in the same subject. Total leukocyte GDH activity was similar in normal subjects and neurological controls. Mean total GDH activity was reduced in all patient groups by between 15 to 29% compared with controls. Fourteen patients had total GDH activity below 50% of the control mean, but low values were not specific for any one disease (five had ataxic disorders, four Parkinson's disease, three multiple system atrophy, one juvenile Parkinsonism, and one dystonia-Parkinsonism). The heat labile fraction of GDH represented about 20% of total activity in control subjects, and 27% in the patients with reduced total GDH activity. Thus low GDH activity was not diseasespecific in this study, and the heat-labile GDH fraction was not selectively affected. "Reduced" leucocyte GDH activity in some patients may represent no more than the lower end of a normal distribution.
The aetiology of most degenerative ataxic disorders is unknown, particularly if the onset of symptoms is in adult life. Although late onset cerebellar ataxia is sometimes inherited as an autosomal dominant trait, many patients do not have similarly affected relatives. Clinical evidence of cerebellar dysfunction is the most prominent finding in both familial and isolated cases, but associated features such as dementia, supranuclear ophthalmoplegia, optic atrophy, extrapyramidal involvement and peripheral neuropathy are common. 1-3 This group of multisystem disorders is often referred to as the olivopontocerebellar atrophies, as degeneration of the inferior olives and pontine nuclei is frequently found at necropsy, together with loss of Purkinje cells and white matter in the cerebellum. This is usually accompanied by degenerative changes in the basal ganglia and spinal cord.4 5 In 1980, Plaitakis and colleagues6 described three adult patients with progressive ataxic disorders who were found to have reduced activity of the enzyme glutamate dehydrogenase (GDH) in leukocytes and skin fibroblasts. About 30 further deficient patients, diagnosed as having olivopontocerebellar atrophy (OPCA) on clinical grounds, have subsequently been described.7-14 Their clinical features were somewhat variable, but the commonest presentation comprised a syndrome of cerebellar ataxia and/or Parkinsonism, often accompanied by bulbar palsy, supranuclear ophthalmoplegia, or an axonal peripheral neuropathy. The age of onset of symptoms ranged from 11 to 79 years. About half of the patients had similarly affected relatives, but no consistent pattern of inheritance was observed. 893 
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Total leukocyte GDH activity ranged from 20 to 70% of mean control values in these cases; the definition of deficiency has tended to be somewhat arbitrary and there has been overlap in levels of enzyme activity between patients and controls.8-10 However, Plaitakis et al'0 and Konagaya and colleagues'4 have suggested that there are two GDH isoenzymes, one heat labile and the other heat stable, with virtually undetectable activity in the heat labile fraction in some cases of OPCA. Furthermore, glutamate loading tests were reported to result in higher plasma glutamate concentrations in deficient patients than in controls.'S-l 7 These observations could be of functional significance as glutamate is known to be neurotoxic. '8 This paper reports the results of a study of leukocyte GDH activity in 71 control subjects and 158 patients with degenerative neurological disorders, including 66 with progressive ataxic syndromes and 32 patients with multiple system atrophy. The (20 ml) was collected in a heparinised syringe, mixed with 5 0 ml of 6% dextran solution, and allowed to stand in the inverted syringe at room temperature for at least 1 hour to allow separation of red blood cells. The supernatant plasma was collected through a bent needle and centrifuged at 4°C for 10 min at 480 g. The resulting leukocyte pellet was suspended in 0 5 ml of isotonic saline (0-154 M NaCl) and 7-0 ml of 0-87% ammonium chloride was added to lyse any erythrocytes trapped in the pellet. After exactly 5 min the suspension was centrifuged again. The resulting pellet was washed at least twice by resuspension in 20 ml ice-cold isotonic saline and recentrifuged at 480 g for 10 min. The pellets were then frozen and stored at -70°C for periods of up to 12 months. On the day of assay, the leukocyte pellet was homogenised in 1-0 ml of 0 05 M Trizma base (tris[hydroxymethyl]-aminomethane), pH 7 4, using a Teflon glass homogeniser, for I min. To the resulting homogenate Triton X-100 was added so as to give a final concentration of 0-15%.
In a preliminary series of studies leukocyte pellets were prepared from four different individuals and GDH activity assayed in the absence of Triton X-100 and in the presence of a range of concentrations of Triton X-100 between Aubby, Saggu, Jenner, Quinn, Harding, Marsden 0 05-0 20%. In each case enzyme activity was increased in the presence ofTriton X-100 compared with results obtained by assaying activity in its absence (table 1) . GDH activity increased between 0-05% and 0-10% Triton X-100 and showed a small further increase at 0-15%. Further increasing the concentration of Triton X-100 to 0-20% caused a decrease in enzyme activity. In subsequent experiments total GDH activity was assayed in the presence of 0-15% Triton X-100.
An aliquot (0 05 ml) of the homogenate was removed for protein estimation and the remainder was used for measurement oftotal GDH activity. GDH processed to produce a leukocyte pellet. All samples were then stored at -70°C. At intervals (I day and 2, 4, 6 and 9 months), individual pellets were assayed for GDH activity as described above. Activity did not decrease over this period but tended to increase with time (GDH activity (nmol/h/mg protein): I day, 734; 2 months, 747; 4 months, 753; 6 months, 880; 9 months 810). (c) Reproducibility ofestimations oftotal GDH activity To determine variations in GDH activity in leukocytes from an individual on different occasions, blood was taken from six subjects on two to six different occasions and the leukocyte pellets were assayed for GDH activity. Little variation was observed. Two separate samples were measured in all six subjects; the difference between the first and second values averaged ± 10-4% (range 4-6 to 15-6%). Six different samples were studied in two subjects; on average the values differed from the means by 6-9% and 3-8% respectively.
(d) The effects of sex and age on GDH activity To determine sex and age effects on GDH activity, enzyme activities in the control subjects were analysed by analysis of variance. In 29 normal male subjects aged between 22- Aliquots (05 ml) of the leukocyte homogenates were transferred to capped plastic tubes and incubated at 47 5°C in a water bath, with agitation. The remaining homogenate was used for estimation of total GDH activity as described above. The samples were removed from the water bath and briefly mixed every 10 minutes to overcome the problem of clotting factors (see below). After 60 minutes incubation the homogenates were removed and assayed for GDH activity. "Heat-stable" GDH was considered to be the activity found after 60 min incubation, whereas "heat-labile" GDH was the value obtained after subtracting the heat-stable from the total activity. Since Triton X-100 has been reported to alter the thermostability of GDH,10 in these experiments Triton Incubation period (min) Aubby, Saggu, Jenner, Quinn, Harding, Marsden no significant difference in total GDH activity determined by the addition of Triton X-100 either prior to or after incubation of the leukocyte homogenates. In leukocyte pellets from 19 individuals, GDH activity with 0-15% Triton X-100 added prior to incubation was 748, SD 245 (mean, 1 SD) nmol/h/mg protein; with Triton X-100 added to the same samples after incubation it was 762, SD 210 nmol/h/mg protein.
In some experiments soluble ("heat stable GDH") and particulate ("heat labile GDH") fractions were separated according to Plaitakis et al.'0 Subcellular fractionation revealed 36-82% (mean 70, SD 7%) of total GDH to be present in the soluble fraction; 10-25% (mean 20, SD 5%) of total activity was found in the particulate fraction; 0-1 % (mean 6%) activity remained in the 480 x g pellet. However, incubation of particulate fractions from five individuals at 47 5'C for up to 80 min caused a variable 20-90% loss of GDH activity (fig IA) . Similarly, incubation of soluble fractions at 47 5°C for up to 80 min resulted in marked variations in GDH activity ranging between a 25% increase to a 65% decrease in enzyme activity ( fig 1B) .
(a) Effect ofincubation time and reproducibility ofheat labile and heat stable estimates of GDH activity in whole leukocyte preparations Incubation of whole homogenates from five individuals at 47 5°C for up to 60 min revealed 100-76% (mean 83%) to be heat stable and 0-24% (mean 17%) of total enzyme activity to be heat labile (fig 2A) . In Control subjects or patients taking drugs known to affect GDH activity (such as steroids and non-steroidal antiinflammatory drugs) were not included. The definition of a low level of GDH activity is arbitrary. We have followed Duvoisin and Chokroverty9 in using the criterion of a value less than 50% ofthe mean level ofactivity in control subjects. When the level of GDH activity was found to be low, the assay was repeated.
To compare mean values for GDH activity in different subject groups, raw data for total GDH activity were logged and an analysis of variance was carried out followed by a two-tailed Student's t test.
Results
Total GDH activity in patients and control subjects ( (196) nmol/h/mg protein (range 437-1148). As there were no significant differences between these two groups, the normal and neurological controls were combined; mean GDH activity in these 71 control subjects was 765, (199) nmol/h/mg protein.
Mean total GDH activity was significantly reduced in the groups of patients with degenerative ataxic disorders, Parkinson's disease, and multiple system atrophy when compared with the combined control group. Mean GDH activity also was low in patients with Steele-Richardson-Olszewski syndrome and juvenile Parkinsonism, although the numbers in these groups were small (table 2) .
There was considerable overlap between values for total GDH activity in individual patients and control subjects (fig 3) . In a total of 14 patients GDH activity was less than 50% of the control mean (that is, less than 383 nmol/h/mg protein). Nine of those 14 patients had total GDH activity values more than two standard deviations below the mean control values (that is, less than 363 nmol/h/mg protein). Five patients had ataxic disorders, four Parkinson's disease, three multiple system atrophy, one juvenile Parkinsonism and one dystonia-Parkinsonism.
Clinicalfeatures ofpatients with GDH activity less than 50% of mean control value 1 Ataxic disorders (1) A 57 year old male developed tremor of the head and hands when aged 44 years and had subsequently noticed progressive gait ataxia and memory loss. (12) A 54 year old male developed erectile impotence at the age of 47, followed some months later by tremor, sialorrhoea, slurring of speech, nocturnal respiratory stridor, difficulty in walking, hesitancy of micturition and urinary incontinence. On examination he had impassive facies, mild cogwheel rigidity in the limbs, bradykinesia, a festinant gait, and mild impairment of cardiovascular reflexes. GDH activity was 366 nmol/h/mg protein. 4 Juvenile Parkinsonism (13) A 49 year old male developed shaking of the head and then the left leg at the age of 17 years. The tremor became increasingly severe and he developed stiffness of his left limbs, spreading to the right. Two sisters and one brother had the same condition, all with onset in late adolescence. On examination he had predominantly left sided Parkinsonism with severe rest tremor of the arm and leg, and rigidity with bradykinesia. Eye movements were normal, tendon reflexes were normal, and plantar responses were flexor. He had only a modest response to levodopa. GDH activity was 365 nmol/h/mg protein. (14) A 64 year old male gave a 20 year history of increasing difficulty with walking due to dragging of his left leg and hyperextension of the back and neck muscles. Fourteen years previously he had developed a rest tremor of the left arm, followed soon after by rapid wasting and Weakness. On examination he had dystonic retrocollis and extensor spasms of the back, particularly on walking, and dystonic posturing of the left leg. There was a rest tremor of the left arm and akinesia of the left arm and leg, but no rigidity. There was wasting and weakness around the left shoulder and upper arm, with absent tendon jerks in the left arm. The ankle jerks were absent but the plantar responses were flexor; appreciation of vibration was reduced slightly at the ankle. He had been.a boxer in the past, and a CT scan showed the presence of a cavum septum pellucidum. Cervical spine radiographs showed marked spondylosis. Nerve conduction studies showed absent sural nerve sensory action potentials, but motor conduction velocity in the legs was normal. GDH activity was 373 nmol/h/mg protein. l-
Fig 4 The distribution of (a) total, (b) heat stable and (c) heat labile GDH activity in leukocyte homogenates from normal and neurological controls compared to patients with total GDH activity less than 50% of the control mean. The bars indicate the mean group values (I SD).
